ST3

Global Architecture Software Market Forecasts, 2021-2022 & 2028: Technological Advancements in Architecture Software & Growing Popularity of Digitalization in Architecture - ResearchAndMarkets.com

Retrieved on: 
Friday, May 13, 2022

Increase in infrastructure projects around the world is one of the major factors driving the growth of the architecture software market.

Key Points: 
  • Increase in infrastructure projects around the world is one of the major factors driving the growth of the architecture software market.
  • As a result, key players operating in the architecture software market use architecture software products to run these projects smoothly and efficiently with improved construction efforts.
  • The growing popularity of digitalization in architecture has created lucrative opportunities for the architecture software market growth.
  • Architects may produce more realistic representations and visualizations using digitalized tools and applications, which further driven the architecture software market.

Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate

Retrieved on: 
Tuesday, September 28, 2021

Saint-Herblain (France) and New York (United States), September 28, 2021 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE), today announced further positive Phase 2 results, including booster response, for Lyme disease vaccine candidate VLA15.

Key Points: 
  • Saint-Herblain (France) and New York (United States), September 28, 2021 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE), today announced further positive Phase 2 results, including booster response, for Lyme disease vaccine candidate VLA15.
  • All participants seroconverted to anti-OspA IgG after the booster dose, meaning Seroconversion Rates (SCRs) were 100% for all OspA serotypes.
  • VLA15 is the only active Lyme disease vaccine candidate in clinical development.
  • Study centers are located in areas where Lyme disease is endemic; volunteers with a prior history of Lyme disease were also enrolled.

KBRA Assigns Preliminary Rating to Upstart Pass-Through Trust, Series 2021-ST3

Retrieved on: 
Thursday, February 25, 2021

Kroll Bond Rating Agency (KBRA) assigns a preliminary rating to one class of notes issued by Upstart Pass-Through Trust, Series 2021-ST3 (UPSPT 2021-ST3), a $64 million consumer loan ABS transaction.

Key Points: 
  • Kroll Bond Rating Agency (KBRA) assigns a preliminary rating to one class of notes issued by Upstart Pass-Through Trust, Series 2021-ST3 (UPSPT 2021-ST3), a $64 million consumer loan ABS transaction.
  • The preliminary rating reflects initial credit enhancement of 36.00%.
  • This transaction represents the twentieth ABS securitization collateralized by unsecured consumer loans originated through the online platform operated by Upstart Network, Inc. (Upstart or the Company) and the ninth series of securities issued from the Upstart Pass-Through Trust (UPSPT, Master Trust) program.
  • KBRA also conducted an operational assessment of Upstart, as well as a review of the transactions legal structure and transaction documents.